CV-Event | P | ||
---|---|---|---|
Yes (n = 23) | No (n = 362) | ||
DAS 28 at follow up, mean (SD) | 3,12 (0,93) | 2,82 (1,37) | 0,252 |
MCV at follow up, mean (SD) | 86,6 (5,97) | 87,2 (5,7) | 0,533 |
RDW at follow up, mean (SD) | 15,1 (2,2) | 14,3 (1,5) | 0,130 |
DMARDs at follow up, n (%) | |||
Methotrexate | 15 (65,2%) | 207 (57,2%) | 0,451 |
Sulfasalazine | 0 | 9 (2,5%) | 0,445 |
Hydroxychloroquine | 2 (8,7%) | 27 (7,5%) | 0,868 |
Leflunomide | 3 (13%) | 15 (4,1%) | 0,050 |
Azathioprine | 0 | 6 (1,7%) | 0,533 |
Glucocorticoids | 8 (34,8%) | 133 (37,5%) | 0,810 |
bDMARD | 8 (34,8%) | 130 (36%) | 0,892 |